within Pharmacolibrary.Drugs.ATC.R;

model R02AX01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.8,
    Cl             = 0.96 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 50 / 1000000,
    adminCount     = 1,
    Vd             = 0.00011999999999999999,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.02,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Flurbiprofen is a nonsteroidal anti-inflammatory drug (NSAID) with analgesic, anti-inflammatory and antipyretic properties. It is used to treat symptoms of pain, inflammation, and fever, and is available as both systemic (oral) and local (lozenge, spray) formulations. Specifically, under the ATC code R02AX01, it is used for sore throat in lozenge or spray form, and is currently approved and in use in many countries.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers after a single oral dose of flurbiprofen.</p><h4>References</h4><ol><li><p>Kaiser, DG, et al., &amp; Lomen, PL (1986). Pharmacokinetics of flurbiprofen. <i>The American journal of medicine</i> 80(3A) 10–15. DOI:<a href=&quot;https://doi.org/10.1016/0002-9343(86)90104-x&quot;>10.1016/0002-9343(86)90104-x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3963013/&quot;>https://pubmed.ncbi.nlm.nih.gov/3963013</a></p></li><li><p>Davies, NM (1995). Clinical pharmacokinetics of flurbiprofen and its enantiomers. <i>Clinical pharmacokinetics</i> 28(2) 100–114. DOI:<a href=&quot;https://doi.org/10.2165/00003088-199528020-00002&quot;>10.2165/00003088-199528020-00002</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7736686/&quot;>https://pubmed.ncbi.nlm.nih.gov/7736686</a></p></li><li><p>Suri, A, et al., &amp; Derendorf, H (1997). Pharmacokinetics and pharmacodynamics of enantiomers of ibuprofen and flurbiprofen after oral administration. <i>International journal of clinical pharmacology and therapeutics</i> 35(1) 1–8. PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/9021434/&quot;>https://pubmed.ncbi.nlm.nih.gov/9021434</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end R02AX01;
